Characterization of hiPSC-neurons from psychosis patients with neurexin-1 deletions
Neurexin-1 缺失精神病患者 hiPSC 神经元的表征
基本信息
- 批准号:9328489
- 负责人:
- 金额:$ 4.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-04 至 2020-04-03
- 项目状态:已结题
- 来源:
- 关键词:AffectAlternative SplicingAnimal ModelBehaviorBipolar DisorderCell Adhesion MoleculesCell LineClinicalClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDelusionsEngineeringExhibitsExonsFoundationsGene ExpressionGeneticGenetic RiskGenetic TranscriptionGenomeGoalsHallucinationsHeritabilityHumanIndividualLinkMediatingMessenger RNAModelingMolecularMorphologyMusMutationNeurodevelopmental DisorderNeuronsPatientsPatternPenetrancePhenotypePopulationPrefrontal CortexProtein IsoformsPsychotic DisordersRNA SplicingRiskRoleSchizophreniaSymptomsSynaptic TransmissionTestingTimeTissue-Specific Gene ExpressionTranscriptUp-RegulationWorkautism spectrum disorderbaseclinical Diagnosiscohortdifferential expressionexcitatory neuronexperienceexperimental studygenetic risk factorgenetic variantimprovedinduced pluripotent stem cellneuropsychiatric disorderneuropsychiatric symptomneurotransmitter releasenovelnucleasepresynapticrisk variantsmall moleculesynaptic functiontargeted sequencing
项目摘要
Project Summary
Heterozygous deletion of neurexin-1 (NRXN1), a presynaptic cell adhesion molecule, is strongly associated with
neuropsychiatric disorders and psychosis. NRXN1 is highly alternatively spliced and recently a role for these
splice isoforms in neuronal identity has been suggested; however, NRXN1 isoforms have not been characterized
in human neurons. Animal models of NRXN1 deletion display deficits in behavior and neuronal activity. However,
animal models cannot recapitulate the effect of myriad patient-specific deletions in the context of other risk
variants within a patient’s genome; together, these effects likely influence the variable penetrance of NRXN1
deletions, which confer a diverse set of clinical diagnoses. Using hiPSC-neurons derived from a rare cohort of
four psychosis patients carrying NRXN1 deletions, this proposal will investigate the casual contribution of these
deletions on gene expression, alternative splicing and neuronal phenotypes in excitatory hiPSC-neurons. There
are three aims: the first is identify differences in alternative splicing in NRXN1 deletion hiPSC-neurons, the
second is to restore isoform deficiencies and manipulate NRXN1 expression in hiPSC-neurons, and the third is
to establish the functional significance of NRXN1 deletion in hiPSC-neurons. My hypothesis is that excitatory
hiPSC-neurons derived from four psychosis patients will exhibit differential expression of NRXN1 isoforms which
are crucial for proper neuronal activity and morphology. We include strong preliminary data demonstrating the
feasibility of our proposal; moreover, we have already observed that NRXN1 hiPSC-neurons express both
wildtype and deleted allele variants. Our hope is that these experiments will improve our understanding of the
molecular mechanisms underlying genetic risk for neuropsychiatric disorders.
项目摘要
突触前细胞粘附分子neurexin-1(NRXN 1)的杂合缺失与
神经精神障碍和精神病。NRXN 1是高度选择性剪接的,最近在这些细胞中起作用。
已经提出了神经元身份中的剪接异构体;然而,NRXN 1异构体尚未被表征
在人类神经元中。NRXN 1缺失的动物模型显示行为和神经元活性的缺陷。然而,在这方面,
动物模型不能概括大量患者特异性缺失在其他风险背景下的作用,
患者基因组内的变异;这些效应可能共同影响NRXN 1的可变突变率。
缺失,这赋予了一组不同的临床诊断。使用来自一个罕见的hiPSC-神经元的队列,
四名携带NRXN 1缺失的精神病患者,这项提案将调查这些患者的偶然贡献。
在兴奋性hiPSC神经元中基因表达、选择性剪接和神经元表型的缺失。那里
有三个目的:第一个是确定NRXN 1缺失hiPSC神经元中选择性剪接的差异,
第二是恢复同种型缺陷并操纵hiPSC神经元中的NRXN 1表达,第三是
建立NRXN 1缺失在hiPSC神经元中的功能意义。我的假设是兴奋性
来自四名精神病患者的hiPSC-神经元将表现出NRXN 1同种型的差异表达,
对正常的神经元活动和形态至关重要。我们包括强有力的初步数据证明,
此外,我们已经观察到,NRXN 1 hiPSC神经元表达
野生型和缺失的等位基因变体。我们希望这些实验能够提高我们对
神经精神疾病遗传风险的分子机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erin Flaherty其他文献
Erin Flaherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erin Flaherty', 18)}}的其他基金
The role of the protocadherin gene cluster in neurodevelopment and the implications for neurodevelopmental disorders
原钙粘蛋白基因簇在神经发育中的作用及其对神经发育障碍的影响
- 批准号:
10808516 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Operating Grants
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Research Grants